Search for: "Novartis Ag" Results 381 - 400 of 440
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
Knockri has partnered with large organizations such as IBM, SAP, Deloitte, Novartis, and many more. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law… [read post]
26 Apr 2021, 7:42 am by Race to the Bottom
Novartis AG is working with Pfizer Inc. to fill vials quicker and to develop the mRNA needed for a new vaccine candidate produced by CureVA NV. [read post]
27 Jul 2011, 1:01 am by Marie Louise
  General Decision for WIPO GA 49: Matters concerning the IGC on IP and genetic resources, traditional knowledge and folklore (KEI) (IP Watch) (IP Watch) Corporate self-interest and strategic choices: Gilead licenses to Medicines Patent Pool (IP Watch) (KEI) Global biotechnology IP evaluation by Scientific American (BIOtechNOW) The Bucknell book – ‘Pharmaceutical, Biotechnology and Chemical Inventions: World Protection and Exploitation’ (The SPC Blog) Dr Reddy’s finds… [read post]
13 Nov 2010, 9:42 am by Vincent LoTempio
Both Advertising Age and Adweek have honored the $2.7 billion agency as “Agency of the Year. [read post]
23 May 2014, 1:39 pm by Schachtman
Novartis AG, California Superior Court, Los Angeles Cty., Transcript of Oral Argument on Post-Trial Motions, at 46 -47 (March 18, 2004) (Hon. [read post]
30 May 2024, 7:11 pm by Dennis Crouch
It also argues that the Federal Circuit’s ruling on PTA is inconsistent with its prior decision in Novartis AG v. [read post]
6 Feb 2023, 6:35 am by Kristi L. Wolff
State AG – GrubHub Deceptive Fee Settlement Sets Standards for Price Disclosures Wait….how much was that takeout? [read post]
15 Dec 2014, 7:25 am
Last week was the busiest in the IPKat's history, with a total of 29 blogposts. [read post]
9 Jan 2014, 1:37 pm
We’ve covered a lot of topics since we started DDLaw in late 2006. [read post]
27 Jul 2009, 7:18 am
: Whirlpool Corporation v Kenwood Ltd (IPKat) EWHC (Pat): EP 258 valid in Netherlands but not UK: Novartis AG and Cibavision AG v Johnson & Johnson Medical Ltd & Ors (IPKat) EWHC (QB): When lawfully seized items can’t be retained under s 22 Police and Criminal Evidence Act 1984 (1709 Copyright Blog) United States US General Obama IP vacancies (IP Frontline) Kappos confirmation hearing set for 29 July (IP Watchdog) (IAM) (Peter Zura's 271… [read post]
21 Oct 2014, 12:00 am
In Novartis AG v Generics (UK) Limited (t/a Mylan) [2012] EWCA Civ1623, discussed by the IPKat (see here) the Court of Appeal had to review the decision of Floyd  J (here) in assessing inventive step where the compound went through several steps during research and development. [read post]
7 Mar 2022, 12:44 am by Rose Hughes
The machinations on the application of Article 3 to combination SPCs is just yet another example of the hazy ground that can open up between these two imperatives.Further reading28 June 2019: SPCs based on a second marketing authorisation - the fight continues (Novartis C-354/19)13 September 2019: Article 3(a) just keeps on giving: AG Opinion in SPC referrals C-650/17 and C-114/1817 May 2021: Does the Irish Court of Appeal in Merck v Clonmel part ways from the… [read post]
13 Sep 2011, 4:26 pm
  Switzerland, home to companies including drugmaker Novartis AG (NOVN) and food company Nestle SA (NESN), was credited for its innovation and technological skills. [read post]
26 May 2010, 3:01 pm by Oliver G. Randl
Novartis AG, where the English judge analyzes the problem-solution approach as practised by the EPO and concludes in paragraph 63 that the decision on the obviousness of the solution provided by the patent under consideration to which he had come would have been the same if the problem-solution approach had been applied). [2.5] In its decision T 665/95 (cited by the impugned decision) the Board has not considered this principle to be an obstacle when it refused further taking of… [read post]
7 Jun 2007, 1:17 am
The lawsuit says Christopher Woods sought treatment for the condition, called severe priapism, the day after he bought the nutrition beverage made by the pharmaceutical company Novartis AG at a drugstore and drank it. [read post]
31 Dec 2020, 7:03 am by Geoff Schweller
Department of Justice announced Novartis AG, a global pharmaceutical and healthcare company based in Switzerland, agreed to pay over $300 million in sanctions to resolve FCPA charges for bribery in Greece. [read post]